anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

225,301-225,360 of 319,975

filter-aware
22
Uses a timeline-style layout to present distinct strategic pillars.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
23
The slide uses a grid layout to categorize product launches by brand and segment.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
24
The slide highlights five specific product categories or launches under the Tork brand.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
25
The slide uses a brand-specific image of a baby to reinforce the 'Libero' brand context.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
26
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
27
The slide uses a mix of corporate financial reporting and product marketing imagery.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
28
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
29
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations 1 hit
30
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations 1 hit
01
Slide 1
Features a 3D molecular visualization.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
02
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a split-screen layout to contrast internal R&D with external partnerships, unified by a central 'discovery programmes' stack.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
04
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
05
Uses a before-after-framing structure to position the company's solution against industry-wide challenges.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
06
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
07
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
08
The slide uses a hub-and-spoke diagram centered on 'Precision Medicine' with six surrounding functional modules.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
09
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
10
The slide uses a horizontal bar chart structure to represent clinical development stages.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
11
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
12
The table provides a clear view of liquidity and operational cash flow trends.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
13
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
14
The diagram uses a double-loop (infinity symbol) structure to represent iterative learning within a linear drug discovery pipeline.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
15
The slide uses a growth-oriented arrow diagram to illustrate technological maturity and value creation.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
16
The slide uses a horizontal timeline framework to map partnerships against target difficulty (GPCRs to novel targets).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
17
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
18
The slide uses a central vertical timeline/process flow with callouts to specific methodology components.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
19
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
20
Uses information theory to explain why 20 binary questions can narrow down a search space of 600,000 items.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
21
The chart uses a series of iterative loop icons to represent the learning process.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
22
The scatter plot highlights a specific cluster of compounds (labeled 1 and 2) that were selected by the active learning model despite being outside the typical high-potency/high-score Pareto frontier.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
23
The slide highlights technical infrastructure and R&D capabilities.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
24
The slide uses a process flow diagram to connect target criteria to computational optimization and final project telemetry.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
25
The diagram uses a hub-and-spoke style flow to show data integration, generative design, and iterative refinement.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
26
The slide features a 3D molecular model and a set of circular gauges representing various drug discovery metrics (potency, stability, toxicity, etc.).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
27
The slide highlights technical capabilities in computational chemistry/drug discovery.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
28
The slide uses a pyramid diagram to show a hierarchical process of drug discovery automation.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
29
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
30
The slide depicts a 'flywheel' or 'closed-loop' process architecture for automated scientific research.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
31
DMT cycle = design-make-test cycleExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
32
The slide uses a combination of icons and a process diagram to illustrate the facility's capabilities.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
33
The slide uses an isometric technical illustration to depict a modular lab automation setup.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses a before-after framing to contrast traditional chemical synthesis methods with the requirements of AI-driven design.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
35
The slide uses a process flow diagram at the top to show the workflow stages, followed by three specific hardware solutions.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
36
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
37
The slide uses a circular process flow to represent the R&D pipeline.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
38
The slide uses a process flow diagram to illustrate a specific patient journey.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
39
Kaplan-Meier survival curves comparing PFS1 (prior treatment) vs PFS2 (study treatment).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
40
The slide uses a linear process flow to explain the study methodology.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
41
The slide uses a complex visual mapping to show drug response across two different biological models (patient samples vs cell lines).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
42
The slide uses a small multiples approach to show dose-response curves for individual patient samples, followed by a summary box plot on the right.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
43
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
44
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
45
The slide features a molecular visualization of the inhibitor.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
46
The slide outlines a standard oncology clinical trial design (dose escalation followed by expansion).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
47
The slide uses a human anatomy diagram to map specific cancer types to their respective organs, providing a visual representation of the addressable market.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
48
The slide uses a biological pathway diagram to explain the mechanism of action and a honeycomb diagram to illustrate market breadth.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
49
The slide uses a three-column layout to define technical requirements for a pharmaceutical product.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
50
The table uses a color-coded heatmap to indicate performance against criteria (green=pass, yellow=minor deviation, red=major deviation).Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
51
The slide presents preclinical efficacy data for a CDK7 inhibitor ('617) in ovarian (OVCAR3) and triple-negative breast cancer (HCC70) models.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit